Treatment outcomes and post-treatment mortality among people with multidrug/rifampicin-resistant tuberculosis in Sierra Leone: a national cohort study

Background

Evidence on biosocial factors driving adverse outcomes in multidrug/rifampicin-resistant tuberculosis (MDR/RR-TB) can inform design of person-centred interventions. We evaluated treatment outcomes, post-treatment mortality, and their associated risk factors among people with multidrug/rifampicin-resistant tuberculosis (MDR/RR-TB) in Sierra Leone.